https://www.viatris-pipeline-tool.com/ 2025-09-29 daily 0.5 https://www.viatris-pipeline-tool.com/pipeline-and-product-portfolio 2026-03-31 daily 0.5 https://www.viatris-pipeline-tool.com/molecule 2026-04-09 daily 0.5 https://www.viatris-pipeline-tool.com/therapy 2025-10-09 daily 0.5 https://www.viatris-pipeline-tool.com/404 2025-09-17 daily 0.5 https://www.viatris-pipeline-tool.com/pipeline-and-product-portfolio/touchscreen 2026-03-12 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/mr-146 2025-10-09 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/ryzumvi 2026-01-09 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/phentolamine 2025-10-09 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/tyrvaya 2025-10-09 daily 0.5 https://www.viatris-pipeline-tool.com/therapy/dim-light-disturbances 2025-11-20 daily 0.5 https://www.viatris-pipeline-tool.com/therapy/dry-eye-disease 2025-10-09 daily 0.5 https://www.viatris-pipeline-tool.com/therapy/neurotrophic-keratopathy 2025-10-09 daily 0.5 https://www.viatris-pipeline-tool.com/therapy/presbyopia 2025-10-09 daily 0.5 https://www.viatris-pipeline-tool.com/therapy/reversal-of-pharmacologically-induced-mydriasis 2025-10-09 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/mr-146/overview 2026-03-16 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/mr-146/pathways 2026-03-16 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/ryzumvi/overview 2025-11-20 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/ryzumvi/pathways 2025-11-20 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/ryzumvi/clinical-trials 2025-11-20 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/phentolamine/overview 2025-11-20 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/phentolamine/pathways 2025-11-20 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/phentolamine/clinical-trials 2026-03-11 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/tyrvaya/overview 2025-10-09 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/tyrvaya/pathways 2025-11-21 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/tyrvaya/clinical-trials 2025-10-09 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/ryzumvi/clinical-trials/mira-2 2026-03-09 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/ryzumvi/clinical-trials/mira-3 2025-12-10 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/ryzumvi/clinical-trials/mira-4 2025-12-10 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/phentolamine/clinical-trials/lynx-1 2026-03-09 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/phentolamine/clinical-trials/lynx-2 2026-03-10 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/phentolamine/clinical-trials/vega-1 2025-12-10 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/phentolamine/clinical-trials/vega-2 2026-03-12 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/phentolamine/clinical-trials/vega-3 2026-03-12 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/tyrvaya/clinical-trials/onset-1 2025-12-10 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/tyrvaya/clinical-trials/onset-2 2026-03-09 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/tyrvaya/clinical-trials/mystic 2025-12-10 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/tyrvaya/clinical-trials/imperial 2025-12-10 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/tyrvaya/clinical-trials/zen 2025-12-10 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/tyrvaya/clinical-trials/cytokine-study 2025-12-10 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/tyrvaya/clinical-trials/onset-2-vs-opus-2-opus-2 2026-03-09 daily 0.5 https://www.viatris-pipeline-tool.com/molecule/tyrvaya/clinical-trials/onset-2-vs-cylcosporine 2026-03-17 daily 0.5